Published in Oncology Business Week, December 3rd, 2006
These promising results will be included in BN ImmunoTherapeutics' current filing for an investigational new drug application (IND) with the U.S. Food and Drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.